{"article":{"annotation":{"article_id":"eu-breast-cancer-screening-rates-2024","available_at":"2026-10-07T03:14:18.711561Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"54bb01525987bc60119824287800e42fe542c73c10a58308426aeaa046f5c2c1","input_sha256":"d78bf9d6c5803c43e0b121e728f7a7e8785f899fd559dcce980cd8245acb8ee6","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[],"rules_sha256":"d28c9c89703b56bd91fd887965d416d0115c2473d4bfbd3e558bcceafc3941dd","schema_version":1,"subjects":[{"concept_id":"medtop:20000447","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: cancer","source_urls":["https://ec.europa.eu/eurostat/en/web/products-eurostat-news/w/edn-20261002-1"]}],"method":"controlled-rules-v1","rule_id":"cancer","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/eu-breast-cancer-screening-rates-2024?lang=en","category":"health","content":{"key_points":[],"paragraphs":["A comparison published by Eurostat on 2 October put the share of eligible women aged 50–69 who had received mammography in the previous two years at 82.1% in Denmark, 82.0% in Sweden and 81.6% in Finland. Hungary was at the lower end, at 27.2%. Sweden's national programme covers a different age range, 40–74.","Against 2019, rates rose in nine EU countries with available data, led by a 12.5 percentage-point increase in Slovakia. Rates were unchanged in Sweden and Finland and fell in 11 other countries; Malta recorded the largest decline, 21.8 percentage points. The figures are administrative data from national screening programmes. Bulgaria and Romania have no national programme, and Greece has no rate data, so country coverage is incomplete. The rates measure programme-based screening, not cancer outcomes."],"sections":[]},"corrections":[{"at":"2026-10-07T00:56:19+03:00","language":"en","text":"German and Portuguese editions and translations of the data and correction explanations have been added to this article."},{"at":"2026-10-07T05:57:28+03:00","language":"en","text":"Data classification corrected: measure identifiers and types now follow the dataset rules. No figure, unit or date changed."}],"country":null,"data":{"blocks":[{"description":{"ar":"معدلات مختارة حسب الدولة والتغيرات منذ 2019 من بيانات برامج 2024 التي أوردها يوروستات في 2 أكتوبر 2026.","de":"Ausgewählte Länderquoten und Veränderungen seit 2019 auf Grundlage der Programmdaten für 2024, die Eurostat am 2. Oktober 2026 meldete.","en":"Selected country rates and changes since 2019 from the 2024 programme data reported by Eurostat on 2 October 2026.","es":"Tasas nacionales seleccionadas y cambios desde 2019, a partir de los datos de programas de 2024 publicados por Eurostat el 2 de octubre de 2026.","fr":"Taux nationaux sélectionnés et évolutions depuis 2019, tirés des données des programmes de 2024 publiées par Eurostat le 2 octobre 2026.","pt":"Taxas de países selecionados e variações desde 2019 com base nos dados dos programas de 2024 informados pelo Eurostat em 2 de outubro de 2026.","tr":"Eurostat'ın 2 Ekim 2026 tarihli haberinde yayımlanan, 2024 program verilerinden seçilmiş ülke oranları ve 2019'a göre değişimler."},"id":"source-indicators","items":[{"basis":"observed","label":{"ar":"معدل الفحص في الدنمارك","de":"Screeningquote in Dänemark","en":"Screening rate in Denmark","es":"Tasa de cribado en Dinamarca","fr":"Taux de dépistage au Danemark","pt":"Taxa de rastreamento na Dinamarca","tr":"Danimarka'da tarama oranı"},"measure":{"aggregation":"rate","frequency":"annual","geography":"denmark","id":"denmark-breast-cancer-screening-rate","periodRole":"reference-period","unitCode":"percent"},"period":"2024","unit":"percent","value":82.1},{"basis":"observed","label":{"ar":"معدل الفحص في المجر","de":"Screeningquote in Ungarn","en":"Screening rate in Hungary","es":"Tasa de cribado en Hungría","fr":"Taux de dépistage en Hongrie","pt":"Taxa de rastreamento na Hungria","tr":"Macaristan'da tarama oranı"},"measure":{"aggregation":"rate","frequency":"annual","geography":"hungary","id":"hungary-breast-cancer-screening-rate","periodRole":"reference-period","unitCode":"percent"},"period":"2024","unit":"percent","value":27.2},{"basis":"observed","label":{"ar":"التغير في سلوفاكيا منذ 2019","de":"Veränderung in der Slowakei seit 2019","en":"Change in Slovakia since 2019","es":"Cambio en Eslovaquia desde 2019","fr":"Évolution en Slovaquie depuis 2019","pt":"Variação na Eslováquia desde 2019","tr":"Slovakya'da 2019'dan beri değişim"},"measure":{"aggregation":"change","frequency":"annual","geography":"slovakia","id":"slovakia-breast-cancer-screening-rate-change-since-2019","periodRole":"reference-period","unitCode":"percentage-point"},"period":"2024","periodStart":"2019","unit":"percentage points","value":12.5},{"basis":"observed","label":{"ar":"التغير في مالطا منذ 2019","de":"Veränderung in Malta seit 2019","en":"Change in Malta since 2019","es":"Cambio en Malta desde 2019","fr":"Évolution à Malte depuis 2019","pt":"Variação em Malta desde 2019","tr":"Malta'da 2019'dan beri değişim"},"measure":{"aggregation":"change","frequency":"annual","geography":"malta","id":"malta-breast-cancer-screening-rate-change-since-2019","periodRole":"reference-period","unitCode":"percentage-point"},"period":"2024","periodStart":"2019","unit":"percentage points","value":-21.8}],"methodology":{"ar":"يمثل المعدل حصة النساء المؤهلات لبرنامج فحص منظم، بعمر 50–69 عاماً، اللواتي خضعن لتصوير الثدي خلال العامين السابقين؛ ويشمل البرنامج السويدي الأعمار 40–74. التغيرات بالنقاط المئوية. لا توجد برامج وطنية في بلغاريا ورومانيا ولا تتوافر بيانات معدل لليونان، لذا لا تدخل هذه الدول في المقارنة؛ ولا تقيس المؤشرات النتائج السريرية.","de":"Die Quote entspricht dem Anteil der für ein organisiertes Programm anspruchsberechtigten Frauen im Alter von 50 bis 69 Jahren, die in den vorangegangenen zwei Jahren eine Mammografie erhielten; das schwedische Programm umfasst 40- bis 74-Jährige. Veränderungen werden in Prozentpunkten angegeben. Bulgarien und Rumänien haben kein nationales Programm, für Griechenland fehlen Quoten; diese Länder sind daher nicht im Vergleich enthalten. Die Indikatoren messen keine klinischen Ergebnisse.","en":"The rate is the share of women aged 50–69 eligible for an organised programme who had mammography in the prior two years; Sweden's programme covers ages 40–74. Changes are percentage points. Bulgaria and Romania have no national programme and Greece has no rate data, so they are not included in this comparison; these indicators do not measure clinical outcomes.","es":"La tasa es la proporción de mujeres de 50 a 69 años elegibles para un programa organizado que se hicieron una mamografía en los dos años anteriores; el programa sueco cubre de 40 a 74 años. Los cambios se expresan en puntos porcentuales. Bulgaria y Rumanía carecen de programa nacional y Grecia no dispone de datos de tasa, por lo que no se incluyen en esta comparación; los indicadores no miden resultados clínicos.","fr":"Le taux correspond à la part des femmes de 50 à 69 ans éligibles à un programme organisé ayant passé une mammographie au cours des deux années précédentes ; le programme suédois couvre les 40–74 ans. Les évolutions sont en points de pourcentage. La Bulgarie et la Roumanie n’ont pas de programme national et la Grèce ne dispose pas de données sur le taux : elles ne figurent donc pas dans la comparaison. Ces indicateurs ne mesurent pas les résultats cliniques.","pt":"A taxa corresponde à parcela de mulheres de 50 a 69 anos elegíveis para um programa organizado que fizeram mamografia nos dois anos anteriores; o programa sueco abrange mulheres de 40 a 74 anos. As variações são expressas em pontos percentuais. Bulgária e Romênia não têm programa nacional e a Grécia não dispõe de dados de taxa, por isso esses países não entram na comparação; os indicadores não medem desfechos clínicos.","tr":"Oran, 50–69 yaşındaki kadınların organize tarama programında uygun nüfusa göre son iki yılda mamografi yaptıran payını gösterir; İsveç programı 40–74 yaşlarını kapsar. Değişimler yüzde puanıdır. Bulgaristan ve Romanya'da ulusal program bulunmadığı, Yunanistan'da oran verisi olmadığı için bu ülkeler karşılaştırmaya dahil değildir; göstergeler klinik sonuçları ölçmez."},"sourceUrls":["https://ec.europa.eu/eurostat/en/web/products-eurostat-news/w/edn-20261002-1"],"title":{"ar":"مؤشرات فحص سرطان الثدي في الاتحاد الأوروبي","de":"Indikatoren zum Brustkrebs-Screening in der EU","en":"EU breast-cancer screening indicators","es":"Indicadores de cribado del cáncer de mama en la UE","fr":"Indicateurs du dépistage du cancer du sein dans l’UE","pt":"Indicadores de rastreamento do câncer de mama na UE","tr":"AB'de meme kanseri tarama göstergeleri"},"type":"metrics","updatedAt":"2026-10-07T00:56:19+03:00"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/eu-breast-cancer-screening-rates-2024/data/source-indicators?lang=en&format=csv","json":"https://newsverum.com/api/v1/articles/eu-breast-cancer-screening-rates-2024/data/source-indicators?lang=en&format=json"},"id":"source-indicators"}],"data_types":["metrics"],"editorial_illustration":{"alt":"Conceptual illustration of public health, research and connected data.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"en","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"event_id":"event-81a46193-6953-5d9e-9ce4-d12fbb5f7ab7","event_period":"2026-10-02","event_period_basis":"event-or-reference-period","id":"eu-breast-cancer-screening-rates-2024","image":null,"importance":0.6,"language":"en","modified_at":"2026-10-07T05:57:28+03:00","publication_basis":"publication-record","published_at":"2026-10-04T14:04:24+00:00","reading_minutes":1,"region":"world","section_illustration":{"alt":"Conceptual illustration of public health, research and connected data.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"en","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"slug":"eu-breast-cancer-screening-rates-2024","sources":[{"checkedAt":"2026-10-04","name":"Eurostat, European Commission","publishedAt":"2026-10-02","url":"https://ec.europa.eu/eurostat/en/web/products-eurostat-news/w/edn-20261002-1"}],"summary":"In 2024, the reported organised screening rate was 82.1% in Denmark and 27.2% in Hungary. Eurostat also reported increases in some countries and declines in others compared with 2019.","text":"In 2024, the reported organised screening rate was 82.1% in Denmark and 27.2% in Hungary. Eurostat also reported increases in some countries and declines in others compared with 2019.\n\nA comparison published by Eurostat on 2 October put the share of eligible women aged 50–69 who had received mammography in the previous two years at 82.1% in Denmark, 82.0% in Sweden and 81.6% in Finland. Hungary was at the lower end, at 27.2%. Sweden's national programme covers a different age range, 40–74.\n\nAgainst 2019, rates rose in nine EU countries with available data, led by a 12.5 percentage-point increase in Slovakia. Rates were unchanged in Sweden and Finland and fell in 11 other countries; Malta recorded the largest decline, 21.8 percentage points. The figures are administrative data from national screening programmes. Bulgaria and Romania have no national programme, and Greece has no rate data, so country coverage is incomplete. The rates measure programme-based screening, not cancer outcomes.\n\nGerman and Portuguese editions and translations of the data and correction explanations have been added to this article.\n\nData classification corrected: measure identifiers and types now follow the dataset rules. No figure, unit or date changed.","title":"Eurostat data show wide gaps in EU breast-cancer screening","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/eu-breast-cancer-screening-rates-2024?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/eu-breast-cancer-screening-rates-2024"},{"api_url":"https://newsverum.com/api/v1/articles/eu-breast-cancer-screening-rates-2024?lang=en","language":"en","url":"https://newsverum.com/en/news/eu-breast-cancer-screening-rates-2024"},{"api_url":"https://newsverum.com/api/v1/articles/eu-breast-cancer-screening-rates-2024?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/eu-breast-cancer-screening-rates-2024"},{"api_url":"https://newsverum.com/api/v1/articles/eu-breast-cancer-screening-rates-2024?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/eu-breast-cancer-screening-rates-2024"},{"api_url":"https://newsverum.com/api/v1/articles/eu-breast-cancer-screening-rates-2024?lang=es","language":"es","url":"https://newsverum.com/es/news/eu-breast-cancer-screening-rates-2024"},{"api_url":"https://newsverum.com/api/v1/articles/eu-breast-cancer-screening-rates-2024?lang=de","language":"de","url":"https://newsverum.com/de/news/eu-breast-cancer-screening-rates-2024"},{"api_url":"https://newsverum.com/api/v1/articles/eu-breast-cancer-screening-rates-2024?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/eu-breast-cancer-screening-rates-2024"}],"url":"https://newsverum.com/en/news/eu-breast-cancer-screening-rates-2024"},"version":"1"}